ADHD (Attention Deficit Hyperactivity Disorder) can affect your child throughout the day
P a y s
a + + e n + /O A
d [u r» i3
c l a s s
I n + e r a c + s
І0 Є + + Є Г W f+K
d a s s f a a + e s
F o c u s e s on
h o m e w o rk
S+ar-fs
CONCERTA
F o r g e t s
h o m
e w o r k
K e e p s
i n t e r r u p t i n g
t e a c h e r
E a t s
l u n c h a l o n e
C O N C ER TA
C A N H ELP Y O U R C H IL D G ET O N TH E PATH TO SUCCESS IN M A N A G IN G A D H D .
• CONCERTA® can help im prove your child's focus
• CONCERTA® im proves social interactions as reported by teachers and parents
• In a survey, 96% o f parents reported th a t th e ir child g o t in trou ble less often at school w hen on CONCERTA®*
• CONCERTA® has over 8 years o f proven safety
ONCE-DAILY
______________
______________
■ START HERE
>
GET THERE
C
O
I U
C
E R
T A
m ethylphenidate HCI
fj]
lSrng.
27
m«i
36
rr«j S
4
r«j
^—
TALKTO YOUR HEALTHCARE PROFESSIONAL ABOUT CONCERTA!
VISIT CONCERTA.NET/BHG OR CALL
1
-
888
-
497-4620
*
This survey was conducted online in the United States by Harris Interactive on behalf of McNeil Pediatrics"*. Division of Ortho-McNeil-Janssen Pharmaceuticals, lnc„ between
May
21
and June
2
.
2008
, among
150
adults who had a child aged
6-17
who had been diagnosed with ADHD and was taking CONCERTA* for more than
3
months at that time.
CONCERTA® is a prescription product approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.
IMPORTANT SAFETY INFORMATION. Talk to
your healthcare professional for a
proper diagnosis and treatment of ADHD
. Only a
healthcare professional can decide whether medication
is right for you or your child. CONCERTA®
should not be taken by patients who have: allergies to
methylphenidate or other ingredients in CONCERTA®
; significant anxiety, tension, or agitation;
glaucoma; tics, Tourette's syndrome, or fam
ily history of Tourette's syndrome; current or past use of monoam
ine oxidase inhibitor (MAOI); esophagus, stomach, or intestinal narrow
ing. Children
under
6
years of age should not take CONCERTA®
Abuse of methylphenidate may lead to
dependence. Tell your healthcare professional if you or your child has had problems w
ith alcohol or
drugs; has had any heart problems, heart defects, high blood pressure, or a
fam
ily history of these problems; has had depression, abnormal thoughts or visions, bipolar d
isorder, or seizure.
Contact your healthcare professional immediately if you oryour child: develops abnormal thinking or hallucinations, abnormal or extreme moods and/or excessive activity; or if aggressive
behavior or hostility develops or worsens while taking CONCERTA®
Your child's healthcare professional should check height and weight often
and may interrupt CONCERTA®
treatment if your
child is not grow
ing or qaining weight as expected. Stimulants may impair the ability of the patient to
operate potentially hazardous machinery or vehicles. Caution should be used
accordingly
until you are reasonably certain that CONCERTA®
does not adversely affect your ability to
engage in such activities. The most common adverse reaction (>
5
%) reported
in children and
adolescents was upper abdom
inal pain. The most common adverse reactions (>
10
%) reported
in adults were dry mouth, nausea, decreased appetite, headache, and insomnia.
Please see Medication Guide on adjacent page.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch.or call
1
-
800
-FDA-
1088
.
access 2 wellness
For information on free or discounted prescription
medications, visit access
2
wellness.com or call
866
-
317
-
2775
.
CONCERTA* is a registered trademark of ALZA Corporation.
©Ortho-McNeil-Janssen Pharmaceuticals. Inc.
2009
May
2009
60
CON
09044
-B
